PRESS RELEASES
-
Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue
November 2, 2021 -
Nanospectra Biosciences Raises First Tranche of Series B-1 Funding Led by Sirtex Medical
September 8, 2020 -
Nanospectra Biosciences Announces Four Additional Prestigious Trial Sites for Pivotal AuroLase Study
August 4, 2020
BLOG HEADLINE
No items found